ProNova Solutions Secures $13.5M Seed Round to Revolutionize Accessible Proton Therapy for Cancer Patients Worldwide

DealMatrix gives you market-realistic EV/Sales and EV/EBITDA multiples for private companies, filtered by sector, stage and region, built on 20 years of data and IPEV-2025-compliant.